Menu Back to 9th-European-Forum-for-Qualified-Person-for-Pharmacovigilance-QPPV-and-Pre-Conference-Workshop


This is the only EU Forum designed for QPPVs by QPPVs, now in its 9th year and ever growing. This year’s objectives, as shown below, build on past successes and have been shaped by valuable feedback provided by participants.

Download Programme

  • Hear the latest updates and hot topics relating to the role of the QPPV
  • Explore long term PV visions, future directions of the ‘PV world’, and potential impact on the role of QPPV
  • Network with colleagues and meet regulators
  • Learn from and share experience and ideas with like-minded and friendly QPPVs in a professional environment
  • Take away practical hints and tips
  • Better understand regulatory and inspectorate expectations of the QPPV
  • Identify the expanded expectations of the role in the context of the new regulatory framework and transparency initiatives
  • Be reassured ("I am not missing anything"), reality check
  • Examine current areas of real challenge

Over time, one of the key successes of the Forum has been the ability to secure continuing support and involvement from key Regulators. Sessions have been open and interactive with attendees appreciating opportunities to raise challenging issues in an informal environment. This 9th Forum aims to continue to attract such key speakers and encourage open debate.

Featured topics

Session 8 discusses the burning issues raised by the participants. Use the opportunity to ask the Expert Panel.

Submit your question

Who should attend?

  • EU PV Qualified Persons and Deputies (present or aspiring), regardless of company size
  • Pharmacovigilance Regulators and Inspectors
  • CRO and Consultants providing QPPV Services
  • National Responsible Persons for Pharmacovigilance
  • Quality Management Personnel
  • Heads of Pharmacovigilance

Program Committee

  • Vicki  Edwards, RPh
    Vicki Edwards, RPh QPPV and Head of Affiliate Vigilance Excellence
    AbbVie Ltd., United Kingdom
  • Margaret Anne Walters
    Margaret Anne Walters Director & Deputy EU Qualified Person for Pharmacovigilance
    Merck, Sharp & Dohme Ltd, United Kingdom
  • Barbara  De Bernardi, MD
    Barbara De Bernardi, MD Deputy EU QPPV and European Safety Office Head
    Pfizer Italia S.r.l., Italy
  • Peter  De Veene, MD
    Peter De Veene, MD Head Global Drug Safety & QPPV
    Grunenthal Gmbh, Germany
  • Brian David Edwards
    Brian David Edwards Principal Consultant, Pharmacovigilance and Drug Safety, Vice-President ACRES
    NDA Regulatory Science Ltd., United Kingdom
  • Shelley  Gandhi, MS
    Shelley Gandhi, MS Strategic Advisor, Pharmacovigilance and Drug Safety
    NDA Group, United Kingdom
  • Elspeth  McIntosh
    Elspeth McIntosh Director
    Castle Pharmacovigilance Ltd, United Kingdom
  • Winrich  Rauschning, DrMed, MD, MBA
    Winrich Rauschning, DrMed, MD, MBA QPPV
    Biolitec Pharma, Germany
  • Michael  Richardson, MD, FFPM
    Michael Richardson, MD, FFPM VP International GPV&E and EU QPPV
    Bristol-Myers Squibb, United Kingdom
  • Doris Irene Stenver, MD, MPA
    Doris Irene Stenver, MD, MPA Chief Medical Officer
    Danish Medicines Agency, Denmark
Load More

Contact us

Registration Questions

Send Email
+41 61 225 51 51

Agenda and Logistics Questions

Send Email
+41 61 225 51 49

Ways to register

Registration fee includes conference delegate material, refreshments and lunches.